Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy

@article{CatherineMackCorrea2012ManagementOP,
  title={Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy},
  author={M. Catherine Mack Correa and Judith Nebus},
  journal={Dermatology Research and Practice},
  year={2012},
  volume={2012}
}
Atopic dermatitis is a common inflammatory skin disorder that afflicts a growing number of young children. Genetic, immune, and environmental factors interact in a complex fashion to contribute to disease expression. The compromised stratum corneum found in atopic dermatitis leads to skin barrier dysfunction, which results in aggravation of symptoms by aeroallergens, microbes, and other insults. Infants—whose immune system and epidermal barrier are still developing—display a higher frequency of… Expand
Guidelines for the management of atopic dermatitis (eczema) for pharmacists
TLDR
These guidelines will discuss in detail different elements of AD assessment and management, and the primary goals of AD management involve the treatment and prevention of AD flares and repair and maintenance of the skin barrier. Expand
Filaggrin and Atopic Dermatitis: Clinical and Pathogenetic Parallels and Therapeutic Possibilities
Atopic dermatitis (AtD) is multifactorial inflammatory skin disease, one of the aspects of its pathogenesis is epidermal barrier dysfunction. Early development of AtD is associated with filaggrinExpand
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies
TLDR
Novel topical therapies are in the pipeline and comprise both new doses and formulations of well-known pharmaceutical molecules and novel approaches targeting unique inflammatory pathways and mechanisms of disease, with a promise of higher efficacy and less harmful side effects. Expand
Update of Treatment Options in Atopic Dermatitis: A Narrative Review
Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by pruritus, inflammatory skin lesions. It causes severe impairment of quality of life along with the impairment ofExpand
Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents.
TLDR
Research on the skin barrier, particularly addressing epidermal differentiation and inflammation, lipid metabolism, and the role of bacterial communities for skin barrier function, will likely expand understanding of the complex etiology of AD and lead to identification of novel targets and the development of new therapies. Expand
Nonpharmacological management of atopic dermatitis
TLDR
Current systemic treatment options available with their individual merit and demerit along with recent advances in this field are dedicated. Expand
Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment and phototherapy
TLDR
The basis for atopic dermatitis treatment and prophylaxis is restoration of epidermal barrier functions by means of tailored emollients, which should effectively eliminate clinical symptoms of the disease, prevent exacerbations as well as complications, and improve patients’ quality of life. Expand
Hydrogels: A Promising Vehicle for the Topical Management of Atopic Dermatitis
TLDR
Hydrogels are explored in the field of cutaneous application and have proven to be a good solution as a topical vehicle for atopic dermatitis, due to their high water content, improved drug delivery, responsiveness to stimuli and versatility in terms of preparation and drug‐loading, representing a good alternative to regular ointments or creams. Expand
Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence
TLDR
Clinical studies showed that moisturization (typically twice daily) significantly improved the skin barrier in adults and children with AD and showed that daily moisturization reduced the incidence of flares and extended the time between flares. Expand
Consensus Conference on Clinical Management of pediatric Atopic Dermatitis
TLDR
Levels and models of intervention are enriched by the Italian experience to facilitate a practical approach to the disease and the therapeutical approach should be adapted to the clinical severity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 153 REFERENCES
Management of Atopic Dermatitis in the Pediatric Population
TLDR
New treatment strategies that are being used by atopic dermatitis specialists, such as comprehensive “education-as-intervention” models, wet wraps, bleach baths, and systemic immunomodulatory therapies are discussed. Expand
Atopic dermatitis: a review of diagnosis and treatment.
TLDR
Treatment should be directed at limiting itching, repairing the skin and decreasing inflammation when necessary, and if pruritus does not respond to treatment, other diagnoses, such as bacterial overgrowth or viral infections, should be considered. Expand
What's new in atopic eczema?
TLDR
The review aims to summarize the most recent findings of more innovative treatment approaches such as modulation of cytokines or chemokines, modulation of T-cell responses or anti-IgE therapy. Expand
The role of microorganisms in atopic dermatitis
  • B. Baker
  • Medicine
  • Clinical and experimental immunology
  • 2006
TLDR
Allergens expressed by the yeast Malazessia furfur, a component of normal skin flora, have also been implicated in disease pathogenesis in a subset of AD patients. Expand
The importance of emollients in treating the increasing incidence of atopic eczema.
TLDR
The key to managing eczema is an effective skin-care routine using emollients to increase hydration of the stratum corneum, and continual therapy using these in combination maximises their beneficial effects. Expand
Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis , allergic contact dermatitis or atopic dermatitis : a multicenter study
Disturbances of skin barrier function occur in several skin diseases, e.g., atopic dermatitis (AD), irritant/allergic contact dermatitis (ICD, ACD). Skin barrier damage triggers the production ofExpand
Guidelines for management of atopic dermatitis
TLDR
The present standard therapies for AD consist of the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation, topical application of emollients to treat the cutaneous physiological dysfunction, systemic antihistamines and anti‐allergic drugs as adjunctive treatments for pruritus, avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. Expand
Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids.
TLDR
The results further support other publications that suggest a treatment approach that incorporates an optimized formulation of a skin barrier repair cream as an integral component of initial atopic dermatitis therapy, either as monotherapy or as part of combination topical therapy. Expand
A pilot study of emollient therapy for the primary prevention of atopic dermatitis.
TLDR
Skin barrier repair from birth represents a novel and feasible approach to AD prevention and further studies are warranted to determine the efficacy of this approach. Expand
Pediatric Atopic Dermatitis: A Review of the Medical Management
TLDR
Emollients are recommended in pediatric patients with a diagnosis of atopic dermatitis regardless of symptoms, and topical corticosteroids reduce the inflammation and pruritus associated with atopy dermatitis and are available in several formulations and strengths. Expand
...
1
2
3
4
5
...